Study of efficacy and safety of pasireotide LAR in patients with inadequately controlled acromegaly

Update Il y a 4 ans
Reference: EUCTR2014-002630-31

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Primary objective: - To evaluate the efficacy of pasireotide LAR in patients with acromegaly who are inadequately controlled with maximal approved doses of currently available somatostatin analogues Supporting Analysis for Primary objective: - To assess the proportion of patients achieving GH <1µg/L and IGF-1 <ULN by GH level.


Inclusion criteria

  • Acromegaly